Lack of De‐Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis
Cancer Medicine · 2026
DOI: 10.1002/cam4.71734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von J M Vahl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Papillomavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
The prognostic relevance of gender in head and neck cancer is often neglected. In contrast, the more favorable prognosis of human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinoma (OPSCC) is well recognized, and de‐escalation strategies are increasingly being tested in clinical trials. In this study, we focused on the prognostic significance of gender to clarify whether it should be given more attention. Patients and Methods We requested data on patients with newly diagnosed head and neck cancer between 2002 and 2017 from the German Center of Cancer Registry ( n = 212,920). First, we focused on sex‐specific survival according to primary tumor site in a nationwide context. Second, we examined a local dataset of 462 OPSCC patients, diagnosed at the University Hospitals of Ulm and Lübeck between 2005 and 2018 and followed up until 2024. Here we compared the prognostic value of sex with HPV status, alcohol consumption, and smoking habits (these parameters were not available at national level).
Results
In the nationwide analysis, women showed better survival in all head and neck primary tumor sites studied. The mean survival difference was greatest in patients with OPSCC (1.3 years; p < 0.0001), followed by patients with nasopharyngeal carcinoma (1 year; p < 0.0001). In the subgroup of patients younger than the median age (62.8 years), women lived on mean 1.2 times longer than men ( p < 0.0001). Besides, in the local dataset, men with HPV‐positive OPSCC did not have a better prognosis than women, even when HPV‐negative ( p = 0.426). However, the prognostic effect of female sex may be attenuated in patients with high tobacco use; in this scenario, no sex‐related difference in survival was found ( p = 0.56).
Conclusion
Sex‐specific differences in survival, especially in OPSCC and nasopharyngeal cancers, suggest the implementation of gender‐sensitive oncology regarding prevention, treatment, and aftercare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Ulm, Ulm, Germany.
- Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Schleswig-Holstein, Lübeck, Germany.
- Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center of the Technical University Munich, Munich, Germany.
ORCID-Profile: J M Vahl, S M Schroeder
Zitieren
APA
Vahl, J. M., Hahn, J., von Witzleben, A., Schroeder, S. M., Idel, C., Wollenberg, B., Hoffmann, T. K., & Laban, S. (2026). Lack of De‐Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis. Cancer Medicine. https://doi.org/10.1002/cam4.71734
Vancouver
Vahl JM, Hahn J, von Witzleben A, Schroeder SM, Idel C, Wollenberg B, et al. Lack of De‐Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis. Cancer Medicine. 2026. doi:10.1002/cam4.71734
BibTeX
@article{Vahl2026,
author = {Vahl, J M and Hahn, J and von Witzleben, A and Schroeder, S M and Idel, C and Wollenberg, B and Hoffmann, T K and Laban, S},
title = {Lack of De‐Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71734}
}
EUVIMED